Fewer new drugs for rare disorders come to Canada relative to the US and Europe. Canada has set-up barriers that delay or deny access to new drugs for many patients with unmet or poorly met healthcare needs. This leaves vulnerable Canadians at a serious disadvantage.
This webinar will highlight how these barriers impact Canadians living with rare disorders, how the federal government made matters worse over the past six years with well-intentioned but poorly conceived plans to reduce drug prices, and why the result has been greater uncertainty and further delays. We will also discuss the impact of a proposed national pharmacare program and alternative ways to help ensure Canadians, especially those with rare disorders, have access to the drugs they need.
Please note, that all registered attendees will receive a post-event recording of the webinar. If you are unable to tune in live, you can watch the recording at your convenience.
Register for this webinar below: